TRSG: financial statements from SEC

Income statement

Metric	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	16m	13m	14m	16m	17m
Cost of revenue	8m	7m	8m	7m	8m
Gross profit	7m	6m	7m	9m	9m
Research and development	975,055	1m	791,762	829,211	669,358
Selling, general and administrative	5m	5m	4m	5m	3m
Operating expenses	7m	6m	6m	6m	4m
Operating income	−241,808	−656,100	1m	3m	5m
Pre-tax income	−39,158	−293,635	1m	3m	5m
Income tax	131,119	−278,082	−537,881	−628,534	709,029
Net income	−170,277	−480,019	856,536	3m	4m
Earnings per share	—	—	0.06	0.19	0.29
Earnings per share, diluted	—	—	0.06	0.19	0.29
Weighted average shares	—	—	15m	15m	15m
Weighted average shares, diluted	—	—	15m	15m	15m

Metric	Aug 19, 2026	Aug 18, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash and equivalents	—	—	7m	9m	11m	13m	11m	6m
Receivables	—	—	—	—	319,589	104,743	—	—
Inventory	—	—	3m	2m	2m	1m	—	—
Current assets	—	—	19m	20m	19m	18m	—	—
Property, plant and equipment	—	—	7m	6m	6m	6m	—	—
Total assets	—	—	30m	30m	27m	26m	—	—
Current liabilities	—	—	10m	11m	9m	8m	—	—
Total liabilities	—	—	11m	13m	11m	11m	—	—
Equity	—	—	18m	17m	16m	15m	12m	8m

Metric	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating cash flow	−3m	−811,889	451,021	4m	6m
Depreciation and amortisation	387,066	365,366	248,146	174,440	207,760
Capital expenditure	799,279	450,637	43,254	145,699	206,345
Investing cash flow	−2m	−3m	−81,745	−104,120	−1m
Dividends paid	—	517,140	1m	2m	—
Financing cash flow	1m	3m	−3m	−1m	−13,421